12 January 2026 - EQT Life Sciences, a part of Swedish private equity company EQT AB (STO: EQT), announced on Monday that it has exited Vivasure Medical Limited, an Ireland-based developer of percutaneous vessel closure technology, through a sale to ...
12 January 2026 - GRIN Therapeutics Inc, a developer of precision therapeutics for neurodevelopmental disorders, announced on Friday that it has dosed the first patient in its global Phase 3 Beeline trial of investigational radiprodil in individuals ...
12 January 2026 - Phanes Therapeutics Inc, a California-based clinical stage biotech company focused on innovative drug discovery and development in oncology, on Friday reported the first clinical data evaluating spevatamig in combination with chemot...
12 January 2026 - Clover Biopharmaceuticals Ltd (HKEX:02197), a China-based commercial-stage biotechnology company, announced on Monday that the first participants have been enrolled in a Phase 2 clinical trial of SCB-1022 (RSV + hMPV) and SCB-1033 (...
9 January 2026 - Swedish biopharmaceutical company Camurus (STO: CAMX), which develops long-acting medicines for severe and chronic diseases, said on Friday that the US Food and Drug Administration (FDA) has accepted for review its resubmitted New Dr...